Current Portfolio
Nkarta
Nkarta is a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies for cancer. Its proprietary platform combines NK cell expansion with precise engineering to enhance tumor targeting and persistence.
Key Facts
- Sector
Life Sciences
- Country
United States
- Fund
LSP 6
- Entry
2019
- Website
- Nkarta
News
Do You Want to Know More?
We are eager to explore how we can achieve great things together.
